Calithera Biosciences (CALA) Stock Price, News & Analysis
Company Description
Calithera Biosciences (OTC Link: CALA) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $24.4K.
CALA has declined 50.0% over the past year. Shares last traded at $0.0001.
For FY2022, Calithera Biosciences reported net income of -$39.6M and diluted earnings per share of -$7.94.
This page collects what Stock Titan holds for CALA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Calithera Biosciences (CALA) stock last closed at $0.0001. Over the past 12 months, the stock has lost 50.0%. At a market capitalization of $24.4K, CALA is classified as a micro-cap stock with approximately 4.9M shares outstanding.
Latest News
Calithera Biosciences has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, clinical trial, fda approval. View all CALA news →
SEC Filings
Financial Highlights
operating income reached -$42.1M, and net income was -$39.6M. Diluted earnings per share stood at -$7.94. The company generated -$43.6M in operating cash flow. With a current ratio of 3.60, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Calithera Biosciences (CALA) currently stands at 7.3 thousand shares, down 0.3% from the previous reporting period, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment. With 41.2 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Calithera Biosciences (CALA) currently stands at 41.2 days, up 131% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 982.2% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 56.9 days.
CALA Company Profile & Sector Positioning
Calithera Biosciences (CALA) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.
Investors comparing CALA often look at related companies in the same sector, including Better For You Wellness Inc (BFYW), DRAZCANNA INC (DZCA), Methes Energies (MEIL), Monkey Rock Group Inc (MKRO), and Biopower Operatn (BOPO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CALA's relative position within its industry.